Letter to the Editor. Copenhagen grading of meningioma

View More View Less
  • 1 Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
  • | 2 University of Copenhagen, Denmark
  • | 3 Karolinska Institutet, Stockholm, Sweden
  • | 4 Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
  • | 5 Odense University Hospital, Clinical Institute, University of Southern Denmark, Odense, Denmark
  • | 6 BRIDGE—Brain Research Inter Disciplinary Guided Excellence, Clinical Institute, University of Southern Denmark, Odense, Denmark
  • | 7 Nuclear Medicine and PET, Copenhagen University Hospital, Copenhagen, Denmark
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $515.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
Print or Print + Online Sign in

Illustration from Serrato-Avila (pp 1410–1423). Copyright Johns Hopkins University, Art as Applied to Medicine. Published with permission.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $515.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
  • 1

    Schwartz TH, McDermott MW. The Simpson grade: abandon the scale but preserve the message. J Neurosurg. 2021;135(2):488495.

  • 2

    Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry. 1957;20(1):2239.

  • 3

    Goldbrunner R, Minniti G, Preusser M, et al. EANO guidelines for the diagnosis and treatment of Meningiomas. Lancet Oncol. 2016;17(9):383391.

  • 4

    Mathiesen T, Pettersson-Segerlind J, Kihlström L, Ulfarsson E. Meningiomas engaging major venous sinuses. World Neurosurg. 2014;81(1):116124.

  • 5

    Borovich B, Doron Y. Recurrence of intracranial meningiomas: the role played by regional multicentricity. J Neurosurg. 1986;64(1):5863.

  • 6

    Adegbite AB, Khan MI, Paine KWE, Tan LK. The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg. 1983;58(1):5156.

  • 7

    Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL. Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg. 1985;62(1):1824.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8

    Jääskeläinen J. Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol. 1986;26(5):461469.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9

    Andersen PK, Geskus RB, de Witte T, Putter H. Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol. 2012;41(3):861870.

  • 10

    Pettersson-Segerlind J, Orrego A, Lönn S, Mathiesen T. Long-term 25-year follow-up of surgically treated parasagittal meningiomas. World Neurosurg. 2011;76(6):564571.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11

    Jadid KD, Feychting M, Höijer J, Hylin S, Kihlström L, Mathiesen T. Long-term follow-up of incidentally discovered meningiomas. Acta Neurochir (Wien). 2015;157(2):225230.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12

    Mathiesen T, Lindquist C, Kihlström L, Karlsson B. Recurrence of cranial base meningiomas. Neurosurgery. 1996;39(1):29.

  • 13

    Boulagnon-Rombi C, Fleury C, Fichel C, Lefour S, Marchal Bressenot A, Gauchotte G. Immunohistochemical approach to the differential diagnosis of meningiomas and their mimics. J Neuropathol Exp Neurol. 2017;76(4):289298.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14

    Afshar-Oromieh A, Giesel FL, Linhart HG, et al. Detection of cranial meningiomas: comparison of 68Ga-DOTATOC PET/CT and contrast-enhanced MRI. Eur J Nucl Med Mol Imaging. 2012;39(9):14091415.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15

    Milker-Zabel S, Zabel-du Bois A, Henze M, et al. Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET. Int J Radiat Oncol Biol Phys. 2006;65(1):222227.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16

    Bashir A, Ziebell M, Fugleholm K, Law I. A potential role of 68Ga-DOTATOC PET in modifying eligibility to surgery in patients with recurrent meningioma. J Nucl Med Radiat Ther. 2015;6 256.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17

    Bashir A, Vestergaard MB, Binderup T, et al. Pharmacokinetic analysis of [68Ga]Ga-DOTA-TOC PET in meningiomas for assessment of in vivo somatostatin receptor subtype 2. Eur J Nucl Med Mol Imaging. 2020;47(11):25772588.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18

    Brouwer de Koning SG, Weijtmans P, Karakullukcu MB, et al. Toward assessment of resection margins using hyperspectral diffuse reflection imaging (400-1,700 nm) during tongue cancer surgery. Lasers Surg Med. 2020;52(6):496502.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19

    Brouwer de Koning SG, Vrancken Peeters MTFD, Jóźwiak K, Bhairosing PA, Ruers TJM. Tumor resection margin definitions in breast-conserving surgery: systematic review and meta-analysis of the current literature. Clin Breast Cancer. 2018;18(4):e595e600.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20

    Goffredo P, Zhou P, Ginader T, et al. I. Positive circumferential resection margins following locally advanced colon cancer surgery: risk factors and survival impact. J Surg Oncol. 2020;121(3):538546.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 21

    Haslund-Vinding J, Skjoth-Rasmussen J, Poulsgaard L, et al. Proposal of a new grading system for meningioma resection: the Copenhagen Protocol. Acta Neurochir (Wien). Published online October 29, 2021. doi: 10.1007/s00701-021-05025-5

    • Search Google Scholar
    • Export Citation
  • 22

    Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016;131(6):803820.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 23

    Mirian C, Skyrman S, Bartek J, et al. The Ki-67 proliferation index as a marker of time to recurrence in intracranial meningioma. Neurosurgery. 2020;87(6):12891298.

  • 24

    Roggendorf W, Schuster T, Peiffer J. Proliferative potential of meningiomas determined with the monoclonal antibody Ki-67. Acta Neuropathol. 1987;73(4):361364.

  • 25

    Abry E, Thomassen IO, Salvesen OO, Torp SH. The significance of Ki-67/MIB-1 labeling index in human meningiomas: a literature study. Pathol Res Pract. 2010;206(12):810815.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26

    Mirian C, Duun-Henriksen AK, Juratli T, et al. Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis. J Neurol Neurosurg Psychiatry. 2020b;91(4):378387.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 27

    Sahm F, Schrimpf D, Stichel D, et al. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol. 2017;18(5):682694.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 1

    Chen WC, Vasudevan HN, Choudhury A, et al. A prognostic gene-expression signature and risk score for meningioma recurrence after resection. Neurosurgery. 2020;88(1):202210.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2

    Nassiri F, Mamatjan Y, Suppiah S, et al. DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management. Neuro Oncol. 2019;21(7):901910.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3

    Prager BC, Vasudevan HN, Dixit D, et al. The meningioma enhancer landscape delineates novel subgroups and drives druggable dependencies. Cancer Discov. 2020;10(11):17221741.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4

    Suppiah S, Nassiri F, Bi WL, et al. Molecular and translational advances in meningiomas. Neuro Oncol. 2019;21(Suppl 1):i4i17.

  • 5

    Magill ST, Vasudevan HN, Seo K, et al. Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningioma. Nat Commun. 2020;11(1):4803.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6

    Verduijn M, Grootendorst DC, Dekker FW, Jager KJ, le Cessie S. The analysis of competing events like cause-specific mortality—beware of the Kaplan-Meier method. Nephrol Dial Transplant. 2011;26(1):5661.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    Pettersson-Segerlind J, Orrego A, Lönn S, Mathiesen T. Long-term 25-year follow-up of surgically treated parasagittal meningiomas. World Neurosurg. 2011;76(6):564571.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8

    Haslund-Vinding J, Skjoth-Rasmussen J, Poulsgaard L, et al. Proposal of a new grading system for meningioma resection: the Copenhagen Protocol. Acta Neurochir (Wien). Published online October 29, 2021. doi: 10.1007/s00701-021-05025-5

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 62 62 62
Full Text Views 30 30 30
PDF Downloads 45 45 45
EPUB Downloads 0 0 0